Literature DB >> 7914477

Abundant TGF alpha precursor and EGF receptor expression as a possible mechanism for the preferential growth of carcinogen-induced preneoplastic and neoplastic hepatocytes in rats.

S Tanno1, K Ogawa.   

Abstract

Expression of transforming growth factor alpha (TGF alpha) was investigated immunohistochemically in preneoplastic and neoplastic hepatocytes induced by the Solt-Farber regimen. Although TGF alpha was almost negative in early lesions comparing carcinogen-altered hepatocytes, it was expressed in approximately 65% of the late lesions. Growth factor localization was predominantly in the cytoplasm or at the bile canalicular membrane within individual lesions, both types being observed at various ratios. Hyperplastic nodules (HPN) predominantly consisting of cells with cytoplasmic type staining showed expansive growth with more abundant expression of EGF receptors (EGFR) and proliferating cell nuclear antigen (PCNA) than those with the membranous localization. The staining patterns of TGF alpha, EGFR and PCNA in hepatocellular carcinomas (HCC) were similar to those of cytoplasmic type growth factor-positive HPN. Western blotting analysis for TGF alpha demonstrated a single 30 kDa protein in lysates of HPN and HCC. Since this protein was broken down to the 6 kDa mature TGF alpha via 20, 16 and 14 kDa forms by treatment with bovine pancreatic elastase, it may represent a physiological precursor. No mature TGF alpha was detected in the conditioned medium of cultured HPN cells, although a small amount of the 30 kDa form was identified. These results suggest that this form of TGF alpha may have an important role in the growth of preneoplastic and neoplastic hepatocytes during rat hepatocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7914477     DOI: 10.1093/carcin/15.8.1689

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  3 in total

1.  Sparse distribution of hepatocyte growth factor-producing cells inside hepatocellular foci in rats treated with hepatocarcinogens.

Authors:  T Imai; M Ichinose; T Yanai; T Masegi; T Nakamura; T Tsukamoto; K Kitoh; M Tatematsu
Journal:  Jpn J Cancer Res       Date:  1997-07

2.  Overproduction of thrombopoietin by BRAFV600E-mutated mouse hepatocytes and contribution of thrombopoietin to hepatocarcinogenesis.

Authors:  Hiroki Tanaka; Kie Horioka; Masahiro Yamamoto; Masaru Asari; Katsuhiro Okuda; Kosuke Yamazaki; Keiko Shimizu; Katsuhiro Ogawa
Journal:  Cancer Sci       Date:  2019-07-30       Impact factor: 6.716

3.  Role of the BrafV637E mutation in hepatocarcinogenesis induced by treatment with diethylnitrosamine in neonatal B6C3F1 mice.

Authors:  Masahiro Yamamoto; Hiroki Tanaka; Bing Xin; Yuji Nishikawa; Kosuke Yamazaki; Keiko Shimizu; Katsuhiro Ogawa
Journal:  Mol Carcinog       Date:  2016-06-10       Impact factor: 4.784

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.